TY  - BOOK
AU  - Davison,Earl
TI  - Macular edema: risk factors, treatment options and long-term outcomes 
T2  - Eye and Vision Research Developments
SN  - 9781633216013
PY  - 2014///]
CY  - New York
PB  - Nova Publishers
KW  - Macula lutea
KW  - Diseases
KW  - Edema
KW  - Eye
KW  - Macula Lutea
KW  - Eye Diseases
N1  - Includes bibliographical references and index; MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; MACULAR EDEMA: RISK FACTORS, TREATMENT OPTIONS AND LONG-TERM OUTCOMES; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: MANAGEMENT OF DIABETIC MACULAR EDEMA BY INTRAVITREAL ANTIANGIOGENIC DRUGS; ABSTRACT; INTRODUCTION; ROLE OF VEGF; PEGAPTANIB (MACUGEN�, PFIZER OPHTHALMICS); RANIBIZUMAB (LUCENTIS�, GENENTECH, NOVARTIS); BEVACIZUMAB (AVASTIN�, ROCHE, GENENTECH); AFLIBERCEPT (EYLEA�, BAYER, REGENERON PHARMACEUTICALS); TREATMENT PROTOCOLS; CONCLUSION; REFERENCES; Chapter 2: MANAGEMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION BY INTRAVITREAL BEVACIZUMABABSTRACT; INTRODUCTION; PATHOGENESIS; TREATMENT; ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR; ANTIANGIOGENIC TREATMENT; INTRAVITREOUS BEVACIZUMAB IN BRVO; INTRAVITREOUS BEVACIZUMAB IN CRVO; ANTI-VEGF IN ISCHEMIC RETINA; TREATMENT PROTOCOLS; CONCLUSION; REFERENCES; Chapter 3: POSTOPERATIVE CYSTOID MACULAR EDEMA IN DIABETIC PATIENTS: PROPHYLAXIS AND MANAGEMENT; ABSTRACT; INTRODUCTION; PATHOGENESIS; PREOPERATIVE CARE; MANAGEMENT; REFERENCES; Chapter 4: MANAGEMENT OF DIABETIC MACULAR EDEMA; ABSTRACTINTRODUCTION; MANAGEMENT OF SYSTEMIC RISK FACTORS; LASER PHOTOCOAGULATION FOR DME; PHARMACOLOGICAL DME TREATMENT; COMBINATION THERAPY FOR DME MANAGEMENT; SURGICAL TREATMENT OF DME; TREATMENT GUIDELINES OF DME; CONCLUSION; REFERENCES; Chapter 5: CURRENT MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY OF DIABETIC MACULAR OEDEMA; PATHOPHYSIOLOGY OF CHRONIC DIABETIC MACULAR OEDEMA; INVESTIGATIONS FOR DMO; LASER TREATMENT IN THE MANAGEMENT OF CHRONIC DIABETIC MACULAR OEDEMA; ANTI-VEGF THERAPIES; INTRAVITREAL STEROIDS TO TREAT CHRONIC DIABETIC MACULAR OEDEMADMO TREATMENT ALGORITHM; FUTURE MANAGEMENT OPTIONS; CONCLUSION; REFERENCES; Chapter 6: MACULAR EDEMA IN IMPORTANT TROPICAL INFECTIONS; ABSTRACT; INTRODUCTION; MACULAR EDEMA IN SOME IMPORTANT TROPICAL INFECTIONS; CONCLUSION; REFERENCES; Chapter 7: CYSTOID MACULAR EDEMA: A DIFFICULT OCULAR DISORDER TO CURE; ABSTRACT; INTRODUCTION; MACULAR HOLE; TREATMENT OF MACULAR EDEMA; CASE REPORT; DISCUSSION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; INDEX
N2  - Macular edema is a serious eye disorder that can be seen in many conditions. Central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are frequent causes of decreased central visual acuity (VA) related to the appearance of macular edema (ME) and ischemia. This book discusses the risk factors, treatment options and long-term outcomes of macular edema. Some of the topics discussed include the management of diabetic macular edema; management of macular edema secondary to retinal vein occulsion by intravitreal bevacizumab; and macular edema in important tropical infections
UR  - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=836693
ER  -